We are live on ! Find out more
MIM

Martin Investment Management Portfolio holdings

AUM $300M
1-Year Est. Return 6.05%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+6.05%
3 Year Est. Return
+44.71%
5 Year Est. Return
+50.94%
10 Year Est. Return
+276.43%
AUM
$460M
AUM Growth
+$37.5M
Cap. Flow
+$3.09M
Cap. Flow %
0.67%
Top 10 Hldgs %
41.82%
Holding
47
New
–
Increased
24
Reduced
18
Closed
–

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$2.35M
2
ORCL icon
Oracle
ORCL
+$990K
3
NOV icon
NOV
NOV
+$948K
4
XOM icon
ExxonMobil
XOM
+$783K
5
ACN icon
Accenture
ACN
+$483K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.39M
2
MA icon
Mastercard
MA
+$1.02M
3
TMO icon
Thermo Fisher Scientific
TMO
+$555K
4
JNJ icon
Johnson & Johnson
JNJ
+$327K
5
VAR
Varian Medical Systems, Inc.
VAR
+$241K

Sector Composition

Rank Sector Weight
1 Healthcare 23.72%
2 Technology 16.31%
3 Energy 16.23%
4 Financials 12.85%
5 Industrials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
1
Mastercard
MA
$497B
$23.8M 5.17%
354,020
-16,250
-4% -$1.02M
AAPL icon
2
Apple
AAPL
$4.99T
$23.5M 5.1%
1,379,952
+2,016
+0.1% +$33.4K
CELG
3
DELISTED
Celgene Corp
CELG
$21.9M 4.75%
284,226
-19,884
-7% -$1.39M
GILD icon
4
Gilead Sciences
GILD
$167B
$19.1M 4.15%
303,784
+144
+0% +$8.61K
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$18.1M 3.93%
196,532
-6,132
-3% -$555K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.11T
$18.1M 3.92%
159,068
+721
+0.5% +$83.2K
ORCL icon
7
Oracle
ORCL
$346B
$17.2M 3.73%
517,615
+30,525
+6% +$990K
NOV icon
8
NOV
NOV
$7.11B
$17.2M 3.73%
243,560
+14,164
+6% +$948K
FISV
9
Fiserv Inc
FISV
$28.9B
$17.1M 3.72%
678,208
-5,596
-0.8% -$135K
MMM icon
10
3M
MMM
$94.1B
$16.6M 3.61%
166,438
-1,373
-0.8% -$134K
HP icon
11
Helmerich & Payne
HP
$3.31B
$16.6M 3.6%
240,659
-1,487
-0.6% -$98.1K
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.07T
$16.6M 3.6%
758,914
-7,749
-1% -$171K
OMC icon
13
Omnicom Group
OMC
$24.6B
$16.3M 3.54%
257,170
+289
+0.1% +$18.4K
JNJ icon
14
Johnson & Johnson
JNJ
$643B
$15.9M 3.46%
183,762
-3,642
-2% -$327K
VAR
15
DELISTED
Varian Medical Systems, Inc.
VAR
$15.9M 3.46%
242,897
-3,802
-2% -$241K
RTX icon
16
RTX Corp
RTX
$295B
$15.8M 3.43%
232,823
-504
-0.2% -$33K
SYK icon
17
Stryker
SYK
$133B
$15.4M 3.34%
227,604
-2,876
-1% -$199K
AXP icon
18
American Express
AXP
$227B
$14.9M 3.23%
197,005
+1,315
+0.7% +$98.9K
CL icon
19
Colgate-Palmolive
CL
$74.2B
$14.8M 3.22%
249,750
-85
-0% -$5.04K
PG icon
20
Procter & Gamble
PG
$347B
$14.6M 3.17%
192,938
+561
+0.3% +$44.6K
VRSK icon
21
Verisk Analytics
VRSK
$27.8B
$14.2M 3.08%
218,549
-1,871
-0.8% -$118K
XOM icon
22
ExxonMobil
XOM
$634B
$14.1M 3.05%
163,382
+8,682
+6% +$783K
CVX icon
23
Chevron
CVX
$374B
$14M 3.03%
114,930
-24
-0% -$2.95K
ABT icon
24
Abbott
ABT
$187B
$9.86M 2.14%
297,071
+67,027
+29% +$2.35M
IBM icon
25
IBM
IBM
$214B
$9.38M 2.04%
52,975
-748
-1% -$136K
1
2

Similar funds

RL
Rogco LP Claremore, Oklahoma $300M AUM 16.35% 1-Year Est. Return
JGIA
Jackson Grant Investment Advisers Stamford, Connecticut $300M AUM 13.94% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
KEM
Kimmeridge Energy Management New York $299M AUM 36.96% 1-Year Est. Return
I
InterCapital Austin, Texas $299M AUM
AFS
Amtrust Financial Services New York $300M AUM 12.98% 1-Year Est. Return
GB
Goepper Burkhardt Greenville, South Carolina $299M AUM 12.16% 1-Year Est. Return
CG
Corundum Group Colorado Springs, Colorado $299M AUM 20.66% 1-Year Est. Return

Martin Investment Management's Q3 2013 Portfolio in Review

As of Q3 2013, Martin Investment Management held 47 positions worth $460M, up 8.9% from $423M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q3 2013: portfolio turnover was 0%. Martin Investment Management opened no new positions and made no exits, leaving the 47-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Energy.

  • Martin Investment Management added most to Abbott in Q3 2013, an estimated $2.35M increase.
  • Martin Investment Management's biggest Q3 2013 reduction was Celgene Corp, cutting an estimated $1.39M.
  • Martin Investment Management's ten largest holdings make up 42% of its $460M portfolio in Q3 2013.
  • Martin Investment Management opened 0 new positions and closed 0 in Q3 2013.
  • Martin Investment Management's portfolio value rose 8.9% quarter-over-quarter to $460M.

Based on Martin Investment Management's 13F filing for Q3 2013, filed 29 Oct 2013.